Deutsche Bank Maintains Hold on HIMS (Hims & Hers) Feb 10, 2026

Deutsche Bank on February 10, 2026 kept a Hold on Hims & Hers Health, Inc. and cut the price target to $31 from $42. The HIMS analyst rating action followed updated revenue and margin assumptions. Investors should weigh the maintained Hold against the new price target and recent price movement, including a 5.98% drop equal to $1.09 since the call.